Paper19716319
Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
Kawai T and 9 others. J Diabetes Complications, 2010. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine. Papers, record 19716319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19716319
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldehyde Reductase | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Neuropathies | Major topic |
| Lysine | Major topic |
| Peripheral Nervous System Diseases | Major topic |
| Rhodanine | Major topic |
| Thiazolidines | Major topic |
| Enzyme Inhibitors | |
| Female | |
| Glycation End Products, Advanced | |
| Humans | |
| Male | |
| Middle Aged | |
| Neural Conduction | |
| Sural Nerve | |
| Tibial Nerve |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41471031 | Enhanced Ocular Delivery of Epalrestat Using Nanostructured Lipid Carrier Laden Soft Contact Lens. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41471031 | PubMed |
| 40002826 | Crumbling Pathogenesis and Biomarkers for Diabetic Peripheral Neuropathy. | Biomedicines | 2025 | https://conductscience.org/library/papers/40002826 | PubMed |
| 38185272 | Aldose reductase is a potential therapeutic target for neurodegeneration. | Chem Biol Interact | 2024 | https://conductscience.org/library/papers/38185272 | PubMed |
| 37082769 | Impact of obstructive sleep apnea syndrome on peripheral nerves and the effect of continuous positive airway pressure: a prospective observational case series. | Postep Psychiatr Neurol | 2021 | https://conductscience.org/library/papers/37082769 | PubMed |
| 36421725 | Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke. | Biomolecules | 2022 | https://conductscience.org/library/papers/36421725 | PubMed |
| 35955863 | Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG). | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955863 | PubMed |
| 33949936 | Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models? | Curr Diabetes Rev | 2022 | https://conductscience.org/library/papers/33949936 | PubMed |
| 32832011 | Understanding Diabetic Neuropathy: Focus on Oxidative Stress. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32832011 | PubMed |
| 32809100 | Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/32809100 | PubMed |
| 31890342 | Study on degradation kinetics of epalrestat in aqueous solutions and characterization of its major degradation products under stress degradation conditions by UHPLC-PDA-MS/MS. | J Pharm Anal | 2019 | https://conductscience.org/library/papers/31890342 | PubMed |
| 31787891 | Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences. | Front Aging Neurosci | 2019 | https://conductscience.org/library/papers/31787891 | PubMed |
| 31636082 | Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. | Dis Model Mech | 2019 | https://conductscience.org/library/papers/31636082 | PubMed |
| 31231498 | Vitamin D suppresses cellular pathways of diabetes complication in liver. | Iran J Basic Med Sci | 2019 | https://conductscience.org/library/papers/31231498 | PubMed |
| 30805403 | The Effect of Vitamin D on Cellular Pathways of Diabetic Nephropathy. | Rep Biochem Mol Biol | 2019 | https://conductscience.org/library/papers/30805403 | PubMed |
| 29731703 | Metabolic Syndrome and Neuroprotection. | Front Neurosci | 2018 | https://conductscience.org/library/papers/29731703 | PubMed |
| 28659153 | Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN). | Lipids Health Dis | 2017 | https://conductscience.org/library/papers/28659153 | PubMed |
| 27306206 | Iridoids are natural glycation inhibitors. | Glycoconj J | 2016 | https://conductscience.org/library/papers/27306206 | PubMed |
| 27073391 | Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway. | Neural Regen Res | 2016 | https://conductscience.org/library/papers/27073391 | PubMed |
| 25821809 | Antioxidant strategies in the management of diabetic neuropathy. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25821809 | PubMed |
| 24634591 | Advanced glycation end products and diabetic complications. | Korean J Physiol Pharmacol | 2014 | https://conductscience.org/library/papers/24634591 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKR1A1 | 10327 | PubTator's text mining | https://conductscience.org/library/genes/10327 | NCBI Gene |
| AKR1B1 | 231 | PubTator's text mining | https://conductscience.org/library/genes/231 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19716319
GET https://conductscience.org/api/papers/v1/19716319/cited_by?page=2